Search for: "ELI LILLY " Results 21 - 40 of 2,169
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
Ozempic Lawsuits Have Been Centralized in Pennsylvania Court
10 Feb 2024, 5:36 am by Moll Law Group
However defendant Eli Lilly filed an objection to being part of the MDL with Novo Nordisk, since it is named in only a small number of lawsuits. [read post]
Illinois Injury and Mass Tort Lawyer Blog - https://www.molllawgroup.com/blog/
A Different Environmental Perspective: February 2024 Report Cates 1980
29 Jan 2024, 4:35 pm
 Pix credit hereCates 1980 has distributed its February 2024 Report. [read post]
Law at the End of the Day - https://lcbackerblog.blogspot.com/
MIAMI BUSINESS LITIGATION: BREACH OF CONTRACT STATUTE OF LIMITATIONS
27 Jan 2024, 9:13 am by Mavrick Law Firm
Eli Lilly & Co., 701 So. 2d 344, 347 (Fla. 1997) (The “statute of limitations for DES negligence actions begins to run on the date the plaintiff knew or should have known of his or her injury”); Fla. [read post]
Florida Business Litigation Lawyer Blog - https://www.mavricklaw.com/blog/
Climate Change Comment Letters: SEC Staff Back At It
7 Jan 2024, 10:55 pm by Meredith Ervine
Here are some of the response letters available on EDGAR for those interested: – Estee Lauder’s first and second response – Eli Lilly’s first, second and third response – Oracle’s first and second response – PENN Entertainment’s first and second response The TL;DR is this: For companies in annual reporting season, know that SEC comments on climate disclosures continue apace, and the Staff is not waiting on final rules. [read post]
TheCorporateCounsel.net Blog - http://www.thecorporatecounsel.net/Blog/
Federal Circuit Affirms Invalidity of Genus Claims to Stevia Production Method Lacking Written Description and Narrower Claims as Combining Natural Phenomena with an Abstract Idea
4 Jan 2024, 9:42 am by Dennis Crouch
Eli Lilly & Co., 598 F.3d 1336 (Fed. [read post]
Patently-O - https://patentlyo.com
Anticipation and Obviousness in Patent Law: An Analysis of Recent IPR Decisions
21 Dec 2023, 9:41 am by Li Guo
Relying on Eli Lilly & Co. v. [read post]
Intellectual Property Law Blog - http://www.intellectualpropertylawblog.com/
The SCOTUS Antibody Ruling Has an Uncertain Impact for Drug Makers and Patients
20 Dec 2023, 5:00 am by Timothy Bonis
Major industry players filed amici briefs on both sides, AbbVie, Bristol Meyers Squibb, and Merck supporting Amgen, and Pfizer, Eli Lilly, Genentech, and AstraZeneca supporting Sanofi. [read post]
Bill of Health - https://blog.petrieflom.law.harvard.edu/
Early Edition: December 19, 2023
19 Dec 2023, 4:48 am by Beatrice Yahia
” Katie Bo Lillis reports for CNN. [read post]
Just Security - https://www.justsecurity.org/
Key U.S. District Court Cases with Implications for IP in the New Year
14 Dec 2023, 12:15 pm by Chad Landmon
Eli Lilly decisions provide a glimpse into what litigants can expect in the aftermath of the GSK v. [read post]
IPWatchdog.com | Patent Copyright Trademark - http://www.ipwatchdog.com
Key U.S. District Court Cases with Implications for IP in the New Year
14 Dec 2023, 12:15 pm by Chad Landmon
Eli Lilly decisions provide a glimpse into what litigants can expect in the aftermath of the GSK v. [read post]
IPWatchdog - http://www.ipwatchdog.com/
When is the use of a product a “substantial noninfringing use” for purposes of Section 271(c)?
11 Dec 2023, 7:43 am by Holman
” citing Eli Lilly and Co. v. [read post]
Patently-O - https://patentlyo.com
David Buchanan appointed co-lead counsel in Insulin Pricing Litigation
7 Dec 2023, 11:17 am by Seeger Weiss
This appointment positions Buchanan at the forefront of a critical legal battle against insulin manufacturers Eli Lilly, Novo Nordisk, and Sanofi – who control nearly the entire U.S. insulin market – as well as the nation’s three largest pharmacy benefit managers (PBMs), CVS Caremark, Express Scripts, and OptumRx, over allegations these companies used unlawful, unfair, and deceptive practices to aggressively hike the cost of insulin and other diabetes medications.… [read post]
Seeger Weiss LLP Blog - https://www.seegerweiss.com/news/
Judge Appoints 2 LPR Attorneys to Leadership Roles in Insulin Pricing Multidistrict Litigation
7 Dec 2023, 6:00 am by Levin Papantonio
The JPML issued a Transfer Order to centralize lawsuits alleging that drug manufacturers and pharmacy benefit manufacturers (PBMs) engaged in an unfair and deceptive conspiracy to orchestrate an insulin pricing scheme.Defendants in these actions include insulin manufacturers Eli Lilly and Company, Novo Nordisk, Inc., and Sanofi-Aventis U.S. [read post]
Levin Papantonio Rafferty Law Firm - https://levinlaw.blogspot.com/
Ketamine is the New Viagra
29 Nov 2023, 5:00 am by Vincent Joralemon
Challengers soon arrived — Bayer’s Levitra and Eli Lilly’s Cialis broke onto the ED scene in the early 2000s. [read post]
Bill of Health - https://blog.petrieflom.law.harvard.edu/
Earnings calls, recall notices not "commercial advertising or promotion," but could be "of and concerning" largest market player
27 Nov 2023, 1:32 pm by Rebecca Tushnet
Recall notice: Eli Lilly & Co. v. [read post]
43(B)log - http://tushnet.blogspot.com/
“PhRMA contributed record sum to GOP-aligned dark money group in 2022, new tax filing reviewed by Issue One shows”
21 Nov 2023, 12:53 pm by Rick Hasen
Release: Pharmaceutical Research and Manufacturers of America — the trade association also known as PhRMA that represents the country’s top drug companies, including Eli Lilly, Merck, and Pfizer — has contributed more than $34.5 million to the Republican-aligned dark money… Continue reading The post “PhRMA contributed record sum to GOP-aligned dark money group in 2022, new tax filing reviewed by Issue One shows” appeared first on Election Law… [read post]
Election Law - http://electionlawblog.org/
Seeger Weiss Represents Arlington County, Virginia in Insulin Pricing Lawsuit
14 Nov 2023, 9:10 am by Seeger Weiss
Seeger Weiss attorneys Chris Seeger, David Buchanan and Steven Daroci filed a lawsuit on behalf of Arlington County, Virginia against insulin manufacturers Eli Lilly, Novo Nordisk, and Sanofi, and pharmacy benefit managers (PBMs) CVS Caremark, Express Scripts and OptumRx, for their alleged role in a scheme to aggressively inflate the price of insulin and other diabetes medications. [read post]
Seeger Weiss LLP Blog - https://www.seegerweiss.com/news/
Eli Lilly Announces a Diabetes Drug Trial for Children
14 Nov 2023, 5:16 am by Moll Law Group
The post Eli Lilly Announces a Diabetes Drug Trial for Children appeared first on Illinois Injury and Mass Tort Lawyer Blog. [read post]
Illinois Injury and Mass Tort Lawyer Blog - https://www.molllawgroup.com/blog/
Philip Morris v Nicoventures – e-cigarettes light up the doctrine of equivalents and Arrow declarations
14 Nov 2023, 4:18 am by Chloe Dickson (Bristows)
  The judge considered these two differences collectively in determining whether PMI’s product infringed as an equivalent (the approach he endorsed in Regen v Estar[2]) under the 3-step test set out in Actavis v Eli Lilly[3]. [read post]
Kluwer Patent Blog - http://patentblog.kluweriplaw.com/
Mounjaro Lawsuits
19 Oct 2023, 5:39 am by Ronald V. Miller, Jr.
Mounjaro is a diabetes drug manufactured by Eli Lilly. [read post]
Lawsuit Information Center - https://www.lawsuit-information-center.com/